Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Venetoclax Combo Shows Promise in Younger Patients With AML

2.

Rural residents continue to have higher odds of skin cancer, study finds

3.

For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.

4.

Thriving while surviving: Understanding the social needs of cancer survivors

5.

Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot